重组人NCR3(天然细胞毒性触发受体3)

特别提示：包括重组人NCR3(天然细胞毒性触发受体3)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人NCR3(天然细胞毒性触发受体3)
英文名称：Recombinant Human Natural Cytotoxicity Triggering Receptor 3
产品货号：JN0538
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Leu19-Thr138在C端含有His标签。

NCR3质量控制：＞95%(还原性SDS-PAGE)

NCR3制剂：冻干品

NCR3保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

NCR3复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于NCR3：
Natural Cytotoxicity Triggering Receptor 3 (NCR3) along with NKp44 and NKp46 constitute a group of receptors termed “Natural Cytotoxicity Receptors”. They play a major role in triggering NK-mediated killing of most tumor cells lines. NKp30 is a type I transmembrane protein having a single extracellular V-like immunoglobulin domain. NKp30 is selectively expressed both in resting and activated human NK cells. In addition, NKp30 is also involved in NK-mediated induction of dendritic cell (DC) maturation. It has been demonstrated that NK cell activation signaling specifically induces lytic activity against several tumor cell types and synthesis of new NF-κB dependent proteins during the initiation of cytotoxicity.

除了重组人NCR3(天然细胞毒性触发受体3),，我公司还供应以下相关产品：


JN0244 重组人(小鼠激活素A) 10μg|50μg|500μg|1mg
JN0476 重组人CD70(TNFSF7) 10μg|50μg|500μg|1mg
JN0614 重组人肺表面活性物质相关蛋白D(SP-D) 10μg|50μg|500μg|1mg
JN0728 重组人半乳糖凝集素14(Galectin-14) 10μg|50μg|500μg|1mg
JN0817 重组人IGFBP-5(胰岛素样生长因子结合蛋白5) 10μg|50μg|500μg|1mg
JN0898 重组人锌指蛋白75A(ZNF75A) 10μg|50μg|500μg|1mg
JN0973 重组小鼠聚集素(Clusterin) 10μg|50μg|500μg|1mg
JN1011 重组人ZC4H2(含锌指蛋白C4H2结构域蛋白) 10μg|50μg|500μg|1mg
JN1034 重组人Parvulin-14(PIN4) 10μg|50μg|500μg|1mg
JN1097 重组人果糖二磷酸醛缩酶C(ALDOC) 10μg|50μg|500μg|1mg
JN1143 重组人GALNT7(N-乙酰氨基半乳糖转移酶7) 10μg|50μg|500μg|1mg
JN1193 重组人排斥性导向分子a(反义导向分子a)(RGMa) 10μg|50μg|500μg|1mg
JN1215 重组人TAC1(Protachykinin-1) 10μg|50μg|500μg|1mg
JN1252 重组人MDH2(线粒体苹果酸脱氢酶) 10μg|50μg|500μg|1mg
JN1813 重组人CD200R1 10μg|50μg|500μg|1mg
ZN1711 人sTNFR1重组蛋白 100ng
MQ0103 重组人粒细胞巨噬细胞集落刺激因子(GM-CSF) 75μg